Search

Search Constraints

You searched for: Author/Creator Halfvarson, Jonas

Search Results

11. Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study. (3rd April 2021)

12. Changes in inflammatory bowel disease subtype during follow-up and over time in 44, 302 patients. (2nd January 2019)

13. Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. (25th February 2022)

14. Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). (2nd November 2018)

15. Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. (2nd November 2021)

17. Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease. Issue 1 (1st January 2021)

18. Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease. Issue 1 (7th July 2020)

19. Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969–2017. Issue 4 (18th August 2022)